Drug pricing

News

AZ halts UK investment, and Lilly, Sanofi follow suit

After MSD's bombshell retreat from a big UK investment plan, AstraZeneca, Lilly, and Sanofi are also pressing pause on new projects.

News

Reaction to MSD's UK exit as government tries to renew talks

The UK government is reported to be trying to restart talks over drug pricing and rebates after MSD's shock decision to scrap a £1bn investment spend.

News

Pharma says UK is 'tumbling down' rankings for investment

The UK is losing out to competitors in attracting investment in R&D, clinical trials, and capital projects, says a report from the ABPI pharma group.

News

Fresh blow to UK life sciences as MSD abandons £1bn project

In a blow to UK life science ambitions, MSD has scrapped a £1bn expansion of its operations in the country, saying it does not value innovation.

News

Lilly pauses Mounjaro orders in UK ahead of price hike

Lilly has paused shipments of weight loss therapy Mounjaro to the UK to prevent stockpiling ahead of a price rise, but patients report shortages.

News

EVERSANA buys digital drug-price marketplace firm Waltz Heal...

EVERSANA has acquired Waltz Health, a Chicago digital health company offering AI-driven marketplaces to lower overall drug costs.

AZ halts UK investment, and Lilly, Sanofi follow suit

Reaction to MSD's UK exit as government tries to renew talks

Pharma says UK is 'tumbling down' rankings for investment

Fresh blow to UK life sciences as MSD abandons £1bn project

Lilly pauses Mounjaro orders in UK ahead of price hike

EVERSANA buys digital drug-price marketplace firm Waltz Heal...

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

Drug pricing

Editor's Picks